## Correct Answer: A. Histone DNA packing into the nucleus is achieved through **histones**, which are small, positively charged proteins rich in lysine and arginine residues. These proteins form the structural core of nucleosomes—the fundamental repeating unit of chromatin. Each nucleosome consists of ~147 base pairs of DNA wrapped around an octamer of histone proteins (2 copies each of H2A, H2B, H3, and H4), with histone H1 serving as a linker histone that stabilizes higher-order chromatin structure. This hierarchical packaging is essential because the ~3 billion base pairs of human DNA must fit into a nucleus only ~10 micrometers in diameter. Without histone-mediated packaging, DNA would extend approximately 2 meters if laid end-to-end. The positive charges on histones electrostatically interact with the negatively charged phosphate backbone of DNA, enabling tight yet reversible binding. Post-translational modifications of histones (acetylation, methylation, phosphorylation) regulate chromatin accessibility and gene expression, making histones not merely structural but also epigenetically regulatory molecules. This concept is foundational to understanding transcriptional regulation, which is critical for NEET PG examinations and clinical practice in understanding genetic diseases and cancer biology. ## Why the other options are wrong **B. Adenine** — Adenine is a nitrogenous base—a component of DNA itself, not a DNA-packaging protein. While adenine pairs with thymine in DNA, it has no structural role in chromatin organization. This is a distractor that confuses the building blocks of DNA with the packaging machinery. Adenine is part of the problem (DNA), not the solution (packaging). **C. Glycoprotein** — Glycoproteins are proteins with covalently attached carbohydrate moieties, typically found in cell membranes, extracellular matrix, and secretory pathways. They have no role in nuclear DNA packaging. This option exploits confusion between different protein classes and their cellular functions—a common NBE trap in biochemistry. **D. Nucleic acid** — Nucleic acids (DNA and RNA) are the molecules being packaged, not the packaging agents. This option represents a fundamental conceptual error—confusing the substrate with the machinery. While nucleic acids interact with proteins, they cannot pack themselves; they require histone proteins for chromatin organization. ## High-Yield Facts - **Nucleosome** = 147 bp DNA + histone octamer (H2A, H2B, H3, H4 × 2 each) + linker histone H1 - **Histone proteins** are rich in basic amino acids (lysine, arginine) enabling electrostatic binding to negatively charged DNA phosphate backbone - **Chromatin levels**: nucleosome → 30 nm fiber → loops → metaphase chromosome (represents ~10,000-fold DNA compaction) - **Histone modifications** (acetylation, methylation) regulate gene expression without changing DNA sequence—epigenetic regulation - **H1 histone** stabilizes higher-order chromatin structure; its removal increases chromatin accessibility and transcription ## Mnemonics **HHHHH (Five H's for Histone Hierarchy)** H2A, H2B, H3, H4 (core octamer) + H1 (linker). Remember: 4 core types × 2 copies + 1 linker = nucleosome. Use when recalling histone composition. **PACK IT UP (DNA Packaging Logic)** Proteins (histones) + Acetylation/modifications + Chromatin structure + Kilobase wrapping + Ionic interactions = DNA Tight packing. Helps recall that packaging requires proteins, not bases or carbohydrates. ## NBE Trap NBE exploits confusion between DNA components (adenine, nucleic acid) and DNA-packaging machinery (histones). Students who conflate "what DNA is made of" with "what packages DNA" fall into this trap. The inclusion of glycoprotein adds a plausible-sounding protein distractor for those unfamiliar with histone-specific function. ## Clinical Pearl In Indian clinical practice, histone modifications are increasingly recognized in cancer biology—histone deacetylase (HDAC) inhibitors are being explored as anti-cancer agents. Understanding histone-mediated chromatin remodeling is essential for comprehending how epigenetic changes drive malignancy, particularly relevant in managing Indian cancer patients where genetic counseling and targeted therapy are becoming standard care. _Reference: Robbins & Cotran Pathologic Basis of Disease, Ch. 1 (Cell Biology); Harper's Illustrated Biochemistry, Ch. 36 (Nucleic Acids); KD Tripathi Essentials of Medical Pharmacology, Ch. 1 (General Principles)_
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.